Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Unsupported browser: Your browser does not meet modern web standards. See how it scores »

One of the problems with artificial skin is its vulnera­bility to infection. Synthetic skin is used in burn treatment and plastic surgery, but blood vessels, which carry the immune system’s machinery, may not connect to the new dermis for a week or two. “Without blood vessels, bacteria can grow and cause infection,” says ­Ioannis Yannas, a bioengineer and materials scientist at MIT who helped develop the first artificial-skin product, approved by the U.S. Food and Drug Administration in the mid-1990s. In a new approach, cultured skin cells are genetically modified to produce higher levels of an antibacterial protein. The cells multiply in the lab and are injected into a collagen matrix of artificial skin. “We’re using genetic modification to try to get the cultured skin to behave more like normal skin,” says Dorothy Supp, a researcher at the Cincinnati Shriners Hospital for Children in Ohio, who led the project. Supp cautions that the engineered cells are far from clinical use: the true test of their bacteria-fighting properties will come in the complex environment of a real wound. The researchers are planning experiments in animal models. The technique could eventually be used to make skin that can sweat and tan after implantation.

0 comments about this story. Start the discussion »

Image by University of Cincinnati

Tagged: Biomedicine, MIT, bacteria, proteins

Reprints and Permissions | Send feedback to the editor

From the Archives